Previous Article | Next Article ![]()
J. Virol., 06 1996, 4121-4124, Vol 70, No. 6
L Fantuzzi, S Gessani, P Borghi, B Varano, L Conti, P Puddu and F Belardelli
We studied the effects of the gp120 glycoprotein of human immunodeficiency
virus type 1 on the expression of interleukin-12 (IL- 12) in human
monocytes and in monocyte-derived macrophages. Induction of the mRNA for
both the p35 and p40 subunits of IL-12 was observed in both cell types
after gp120 treatment. We then evaluated cytokine secretion by using an
enzyme-linked immunosorbent assay which recognizes only the IL-12
heterodimer. No IL-12 was detected in monocytes/macrophages treated with
gp120 alone. A consistent IL-12 secretion was found in macrophages primed
with gamma interferon (IFN- gamma) and subsequently treated with gp120. Low
levels of IL-12 were occasionally observed in IFN-gamma-primed monocytes
stimulated with gp120. The greater response of macrophages than of
monocytes to the priming effect of IFN-gamma was consistent with the
finding that IFN- gamma induced a much stronger antiviral state to
vesicular stomatitis virus in macrophages than in monocytes. These data
indicate that gp120 is an inducer of IL-12 expression in
monocytes/macrophages and that IFN- gamma is an essential cofactor for
IL-12 secretion, especially in differentiated macrophages.
Copyright © 1996, American Society for Microbiology
Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma interferon for IL-12 secretion
Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|